OncoCyte Corporation (OCX) Gained 6.45% or 0.1 To Price $1.65 On Friday


OncoCyte Corporation (OCX) gained 6.45% or 0.1 to $1.65. It is about 37719 shares traded, which is 110.34% compare to the average total volume 34185. The market cap of OCX is $67.10 million. The year to date change is 11.89%. The 52 week price range is from $1.1 to $4.65. Price of OCX have changed 6.90% during last week. It have changed -10.92% over last month, -39.22% over last 3 months, -41.51% over last 6 months and -65.56% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for OCX is 1.67. It is 1.21% above current price. The 200-day Moving Averages for OCX is 2.24. It is 35.76% above current price. The 52-week High is 4.65. It is 181.82% from the current price. The 52-week Low is 1.1. It is -33.33% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of OCX is 12.14 on 2018-12-14. Short % to float is 1.05%. There are some statistics of OCX. It is has market cap $67.10 million. The share outstanding is 40.66 million. The average volume is 34185. The percent of top 15 Institution holding is 23.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of OCX is -196.45%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of OCX is -112.66%.


Tags:

Share this post